The DOI matches its Crossref record; 224 of the 224 references it cites were found in a registry or an index.
Phospholipids and cholesterol: Inducers of cancer multidrug resistance and therapeutic targets
Open accessAbstract
Lipids, phospholipids and cholesterol in particular, are the predominant components of the plasma membrane, wherein multidrug efflux transporters of the ATP-binding cassette (ABC) superfamily reside as integral pump proteins. In the current review, we discuss how lipids potently modulate the expression and activity of these multidrug efflux pumps, contributing to the development of the multidrug resistance (MDR) phenotype in cancer. The molecular mechanisms underlying this modulation of the MDR phenotype are pleiotropic. First, notwithstanding the high intra-and inter-tumor variability, MDR cells display an altered composition of plasma membrane phospholipids and glycosphingolipids, and are enriched with very long saturated fatty acid chains. This feature, along with the increased levels of cholesterol, decrease membrane fluidity, alter the spatial organization of membrane nano- and micro-domains, interact with transmembrane helices of ABC transporters, hence favoring drug binding and release. Second, MDR cells exhibit a peculiar membrane lipid composition of intracellular organelles including mitochondria and endoplasmic reticulum (ER). In this respect, they contain a lower amount of oxidizable fatty acids, hence being more resistant to oxidative stress and chemotherapy-induced apoptosis. Third, drug resistant cancer cells have a higher ratio of monosatured/polyunsatured fatty acids: this lipid signature reduces the production of reactive aldehydes with cytotoxic and pro-inflammatory activity and, together with the increased activity of anti-oxidant enzymes, limits the cellular damage induced by lipid peroxidation. Finally, specific precursors of phospholipids and cholesterol including ceramides and isoprenoids, are highly produced in MDR cells; by acting as second messengers, they trigger multiple signaling cascades that induce the transcription of drug efflux transporter genes and/or promote a metabolic reprogramming which supports the MDR phenotype. High-throughput lipidomics and computational biology technologies are a great tool in analyzing the tumor lipid signature in a personalized manner and in identifying novel biomarkers of drug resistance. Moreover, beyond the induction of MDR, lipid metabolism offers a remarkable opportunity to reverse MDR by using lipid analogues and repurposing lipid-targeting drugs (e.g. statins and aminobisphosphonates) that reprogram the lipid composition of drug resistant cells, hence rendering them drug sensitive.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Riganti, C., Castella, B., Kopecka, J., Campia, I., Coscia, M., Pescarmona, G., Bosìa, A., Ghigo, D., & Massaia, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060975 · Cited by 50
Self-citationRetractedChemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
Esterbauer, H., Schaur, R. J., & Zollner, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90192-6 · Cited by 6,672
Mesopelagic fish biomass and trophic efficiency of the open ocean
Irigoien, X., Klevjer, J., Røstad, A., Martínez, U., Boyra, G., Acuña, J. L., Bode, A., Echevarrı́a, F., González-Gordillo, J. L., Hernández‐León, S., et al. (2014) · DIGITAL.CSIC (Spanish National Research Council (CSIC)) · Cited by 1,813
The Ras superfamily at a glance
Wennerberg, K., Rossman, K. L., & Der, C. J. (2005) · Journal of Cell Science · doi:10.1242/jcs.01660 · Cited by 1,352
Tumor targeting via EPR: Strategies to enhance patient responses
Golombek, S. K., May, J.-N., Theek, B., Appold, L., Drude, N., Kiessling, F., & Lammers, T. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.07.007 · Cited by 1,262
Sphingolipid metabolism in cancer signalling and therapy
Ogretmen, B. (2018) · Nature Reviews Cancer · doi:10.1038/nrc.2017.96 · Cited by 1,207
Liu, S., Cong, Y., Wang, D., Sun, Y., Deng, L., Liu, Y., Martin-Trevino, R., Shang, L., McDermott, S. P., Landis, M. D., et al. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2013.11.009 · Cited by 1,053
Ceramide-orchestrated signalling in cancer cells
Morad, S. A. F., & Cabot, M. C. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3398 · Cited by 1,014
RAS isoforms and mutations in cancer at a glance
Hobbs, G. A., Der, C. J., & Rossman, K. L. (2016) · Journal of Cell Science · doi:10.1242/jcs.182873 · Cited by 973
Horvath, S. E., & Daum, G. (2013) · Progress in Lipid Research · doi:10.1016/j.plipres.2013.07.002 · Cited by 907
(2002) · PubMed · Cited by 840
Vistoli, G., De Maddis, D., Cipak, A., Zarkovic, N., Carini, M., & Aldini, G. (2013) · Free Radical Research · doi:10.3109/10715762.2013.815348 · Cited by 823
The Role of Cholesterol in Cancer
Kuzu, O. F., Noory, M. A., & Robertson, G. P. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2613 · Cited by 708
The TAM family: phosphatidylserine-sensing receptor tyrosine kinases gone awry in cancer
Graham, D. K., DeRyckere, D., Davies, K. D., & Earp, H. S. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3847 · Cited by 698
Computational Modeling of Realistic Cell Membranes
Marrink, S. J., Corradi, V., Souza, P. C. T., Ingólfsson, H. I., Tieleman, D. P., & Sansom, M. S. P. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00460 · Cited by 694
Ordering effects of cholesterol and its analogues
Róg, T., Pasenkiewicz-Gierula, M., Vattulainen, I., & Karttunen, M. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.08.022 · Cited by 609
Ribas, V., GarcÃa-Ruiz, C., & Fernández-Checa, J. C. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00151 · Cited by 571
Chemistry and biochemistry of lipid peroxidation products
Guéraud, F., Atalay, M., Bresgen, N., Cipak, A., Eckl, P. M., Huc, L., Jouanin, I., Siems, W., & Uchida, K. (2010) · Free Radical Research · doi:10.3109/10715762.2010.498477 · Cited by 552
Hilvo, M., Denkert, C., Lehtinen, L., Müller, B., Brockmöller, S., Seppänen-Laakso, T., Budczies, J., Bucher, E., Yetukuri, L., Castillo, S., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3894 · Cited by 532
Relation Between Mitochondrial Membrane Potential and ROS Formation
Suski, J. M., Lebiedzinska, M., Bonora, M., Pinton, P., Duszynski, J., & Wieckowski, M. R. (2012) · Methods in Molecular Biology · doi:10.1007/978-1-61779-382-0_12 · Cited by 522
Lysosomes as mediators of drug resistance in cancer
Zhitomirsky, B., & Assaraf, Y. G. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2015.11.004 · Cited by 482
Self-citationStructural insight into substrate and inhibitor discrimination by human P-glycoprotein
Alam, A., Kowal, J., Broude, E., Roninson, I., & Locher, K. P. (2019) · Science · doi:10.1126/science.aav7102 · Cited by 469
Beale, A. D., Pedrazzoli, M., Gonçalves, B. D. S. B., Beijamini, F., Duarte, N. E., Egan, K. J., Knutson, K. L., Schantz, M. V., & Roden, L. C. (2017) · Scientific Reports · doi:10.1038/s41598-017-05712-3 · Cited by 461
Emerging Diversity in Lipid–Protein Interactions
Corradi, V., Sejdiu, B. I., Mesa-Galloso, H., Abdizadeh, H., Noskov, S. Y., Marrink, S. J., & Tieleman, D. P. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00451 · Cited by 459
Cytochrome c/cardiolipin relations in mitochondria: a kiss of death
Kagan, V. E., Bayır, H. A., Belikova, N. A., Kapralov, O., Tyurina, Y. Y., Tyurin, V. A., Jiang, J., Stoyanovsky, D. A., Wipf, P., Kochanek, P. M., et al. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.03.004 · Cited by 444
Unraveling the Truth About Antioxidants: Mitohormesis explains ROS-induced health benefits
Ristow, M. (2014) · Nature Medicine · doi:10.1038/nm.3624 · Cited by 417
Dysregulation of the mevalonate pathway promotes transformation
Clendening, J. W., Pandyra, A., Boutros, P. C., Ghamrasni, S. E., Khosravi, F., Trentin, G. A., Martirosyan, A., Hakem, A., Hakem, R., Jurisica, I., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910258107 · Cited by 417
Furuta, E., Pai, S. K., Zhan, R., Bandyopadhyay, S., Watabe, M., Mo, Y.-Y., Hirota, S., Hosobe, S., Tsukada, T., Miura, K., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2489 · Cited by 392
Cell membrane modulation as adjuvant in cancer therapy
Zalba, S., & ten Hagen, T. L. M. (2017) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2016.10.008 · Cited by 365
Cotte, A. K., Aires, V., Fredon, M., Limagne, E., Derangère, V., Thibaudin, M., Humblin, E., Scagliarini, A., de Barros, J.-P. P., Hillon, P., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02732-5 · Cited by 359
Hillgren, K. M., Keppler, D., Zur, A. A., Giacomini, K. M., Stieger, B., Cass, C. E., & Zhang, L. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.74 · Cited by 352
The role of cholesterol metabolism in cancer.
Ding, X., Zhang, W., Li, S., & Yang, H. (2019) · Europe PMC (PubMed Central) · Cited by 336
An LXR-Cholesterol Axis Creates a Metabolic Co-Dependency for Brain Cancers
Villa, G. R., Hulce, J. J., Zanca, C., Bi, J., Ikegami, S., Cahill, G. L., Gu, Y., Lum, K. M., Masui, K., Yang, H., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.09.008 · Cited by 325
Acetyl-CoA Metabolism Supports Multistep Pancreatic Tumorigenesis
Carrer, A., Trefely, S., Zhao, S., Campbell, S. L., Norgard, R. J., Schultz, K. C., Sidoli, S., Parris, J. L. D., Affronti, H. C., Sivanand, S., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0567 · Cited by 313
Collateral sensitivity as a strategy against cancer multidrug resistance
Pluchino, K. M., Hall, M. D., Goldsborough, A. S., Callaghan, R., & Gottesman, M. M. (2012) · Drug Resistance Updates · doi:10.1016/j.drup.2012.03.002 · Cited by 305
Sterol regulatory element binding protein 1 couples mechanical cues and lipid metabolism
Bertolio, R., Napoletano, F., Mano, M., Maurer-Stroh, S., Fantuz, M., Zannini, A., Bicciato, S., Sorrentino, G., & Del Sal, G. (2019) · Nature Communications · doi:10.1038/s41467-019-09152-7 · Cited by 297
Enkavi, G., Javanainen, M., Kulig, W., Róg, T., & Vattulainen, I. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00538 · Cited by 289
Inflammation, ROS, and Mutagenesis
El-Kenawi, A., & Ruffell, B. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.11.015 · Cited by 280
Sharom, F. J. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00041 · Cited by 278
Mitochondrial Cholesterol Contributes to Chemotherapy Resistance in Hepatocellular Carcinoma
Montero, J., Morales, A., Llacuna, L., Lluis, J. M., Terrones, O., Basañez, G., Antonsson, B., Prieto, J., García-Ruiz, C., Colell, A., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6161 · Cited by 276
Szymański, J., Janikiewicz, J., Michalska, B., Patalas-Krawczyk, P., Perrone, M., Ziółkowski, W., Duszyński, J., Pinton, P., Dobrzyń, A., & Więckowski, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071576 · Cited by 268
Bougnoux, P., Hajjaji, N., Ferrasson, M. N., Giraudeau, B., Couet, C., & Le Floch, O. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605441 · Cited by 264
Nuclear lamina integrity is required for proper spatial organization of chromatin in Drosophila
Ulianov, S. V., Doronin, S. A., Khrameeva, E. E., Kos, P. I., Luzhin, A. V., Starikov, S. S., Galitsyna, A. A., Nenasheva, V. V., Ilyin, A. A., Flyamer, I. M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09185-y · Cited by 251
MsbA-dependent Translocation of Lipids across the Inner Membrane of Escherichia coli
Doerrler, W. T., Gibbons, H. S., & Raetz, C. R. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408106200 · Cited by 236
Singhal, S. S., Singh, S. P., Singhal, P., Horne, D., Singhal, J., & Awasthi, S. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.10.006 · Cited by 235
4-Hydroxynonenal in the Pathogenesis and Progression of Human Diseases
Shoeb, M., Ansari, N., Srivastava, S., & Ramana, K. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990181 · Cited by 230
Membrane-lipid therapy: a new approach in molecular medicine
Escribá, P. V. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.11.004 · Cited by 228
Zhitomirsky, B., & Assaraf, Y. G. (2015) · Oncotarget · doi:10.18632/oncotarget.2732 · Cited by 225
Self-citation4-Hydroxynonenal (HNE) modified proteins in metabolic diseases
Castro, J. P., Jung, T., Grune, T., & Siems, W. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.10.497 · Cited by 225
Murphy, R. A., Mourtzakis, M., Chu, Q. S. C., Baracos, V. E., Reiman, T., & Mazurak, V. C. (2011) · Cancer · doi:10.1002/cncr.25933 · Cited by 221
Lipid metabolism in prostate cancer.
Wu, X., Daniels, G., Lee, P., & Monaco, M. E. (2014) · PubMed · Cited by 212
PERK induces resistance to cell death elicited by endoplasmic reticulum stress and chemotherapy
Salaroglio, I. C., Panada, E., Moiso, E., Buondonno, I., Provero, P., Rubinstein, M., Kopecka, J., & Riganti, C. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0657-0 · Cited by 206
Self-citationLipids as a Target for Drugs Modulating Multidrug Resistance of Cancer Cells
Hendrich, A., & Michalak, K. (2003) · Current Drug Targets · doi:10.2174/1389450033347172 · Cited by 205
Anticancer Activity of the Cholesterol Exporter ABCA1 Gene
Smith, B., & Land, H. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.08.011 · Cited by 204
Dany, M., Gencer, S., Nganga, R., Thomas, R. J., Oleinik, N., Baron, K. D., Szulc, Z. M., Ruvolo, P., Kornblau, S., Andreeff, M., et al. (2016) · Blood · doi:10.1182/blood-2016-04-708750 · Cited by 201
Statin drugs to reduce breast cancer recurrence and mortality
Beckwitt, C. H., Brufsky, A., Oltvai, Z. N., & Wells, A. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-1066-z · Cited by 197
Cebecauer, M., Amaro, M., Jurkiewicz, P., Sarmento, M. J., Šachl, R., Cwiklik, L., & Hof, M. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00322 · Cited by 195
Non‐small cell lung cancer is characterized by dramatic changes in phospholipid profiles
Marien, E., Meister, M., Muley, T., Fieuws, S., Bordel, S., Derua, R., Spraggins, J., Van de Plas, R., Dehairs, J., Wouters, J., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29517 · Cited by 193
Association of tamoxifen resistance and lipid reprogramming in breast cancer
Hultsch, S., Kankainen, M., Paavolainen, L., Kovanen, R.-M., Ikonen, E., Kangaspeska, S., Pietiäinen, V., & Kallioniemi, O. (2018) · BMC Cancer · doi:10.1186/s12885-018-4757-z · Cited by 193
Drori, S., Eytan, G. D., & Assaraf, Y. G. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.1020m.x · Cited by 179
Self-citationRegev, R., Assaraf, & Eytan, G. D. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00037.x · Cited by 171
Marcoux, J., Wang, S. C., Politis, A., Reading, E., Ma, J., Biggin, P. C., Zhou, M., Tao, H., Zhang, Q., Chang, G., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303888110 · Cited by 170
Lipidomic profiling of extracellular vesicles derived from prostate and prostate cancer cell lines
Brzozowski, J. S., Jankowski, H., Bond, D. R., McCague, S. B., Munro, B. R., Predebon, M. J., Scarlett, C. J., Skelding, K. A., & Weidenhofer, J. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0854-x · Cited by 168
Yang, R., Xiu, H., Zhou, Q., Sun, L., Mu, H., Li, H., Wang, S., Li, X., Chen, W., & Dong, J. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/4809836 · Cited by 166
Lysosomal accumulation of anticancer drugs triggers lysosomal exocytosis
Zhitomirsky, B., & Assaraf, Y. G. (2017) · Oncotarget · doi:10.18632/oncotarget.15155 · Cited by 163
Self-citationMitochondria, cholesterol and cancer cell metabolism
Ribas, V., García‐Ruiz, C., & Fernández‐Checa, J. C. (2016) · Clinical and Translational Medicine · doi:10.1186/s40169-016-0106-5 · Cited by 159
Mitochondrial cholesterol import
Elustondo, P., Martin, L. A., & Karten, B. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.08.012 · Cited by 159
Pathophysiological relevance of aldehydic protein modifications
Žarković, N., Gašparović, A. Č., Jaganjac, M., Borović, S., & Žarković, K. (2013) · Journal of Proteomics · doi:10.1016/j.jprot.2013.02.004 · Cited by 155
Self-citationAlizadeh, J., Zeki, A. A., Mirzaei, N., Tewary, S., Moghadam, A. R., Głogowska, A., Nagakannan, P., Eftekharpour, E., Wiecheć, E., Gordon, J. W., et al. (2017) · Scientific Reports · doi:10.1038/srep44841 · Cited by 149
Evaluating the evidence for targeting FOXO3a in breast cancer: a systematic review
Taylor, S., Lam, M., Pararasa, C., Brown, J. E. P., Carmichael, A. R., & Griffiths, H. R. (2015) · Cancer Cell International · doi:10.1186/s12935-015-0156-6 · Cited by 146
Zhong, H., Xiao, M., Žarković, K., Zhu, M., Sa, R., Lu, J., Tao, Y., Chen, Q., Xia, L., Cheng, S., et al. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.10.494 · Cited by 145
Controversy about pharmacological modulation of Nrf2 for cancer therapy
Milković, L., Žarković, N., & Saso, L. (2017) · Redox Biology · doi:10.1016/j.redox.2017.04.013 · Cited by 144
Bernard, M. E., Glaser, S., Gill, B. S., et al. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00001 · Cited by 143
Vitamin E: Regulatory Role on Signal Transduction
Zingg, J.-M. A. (2018) · IUBMB Life · doi:10.1002/iub.1986 · Cited by 142
The asymmetry of plasma membranes and their cholesterol content influence the uptake of cisplatin
Rivel, T., Ramseyer, C., & Yesylevskyy, S. O. (2019) · Scientific Reports · doi:10.1038/s41598-019-41903-w · Cited by 142
Mevalonate Pathway and Human Cancers
Tamanoi, F., Azizian, M., Ashrafi, M., & Bathaie, S. Z. (2016) · Current Molecular Pharmacology · doi:10.2174/1874467209666160112123205 · Cited by 134
Lucken‐Ardjomande, S., Montessuit, S., & Martinou, J. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402280 · Cited by 132
Suhaili, S. H., Karimian, H., Stellato, M., Lee, T.-H., & Aguilar, M. (2017) · Biophysical Reviews · doi:10.1007/s12551-017-0308-0 · Cited by 132
Aglago, E. K., Huybrechts, I., Murphy, N., Casagrande, C., Nicolas, G., Pischon, T., Fedirko, V., Severi, G., Boutron‐Ruault, M., Fournier, A., et al. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.06.031 · Cited by 132
Structure–Kinetic Relationships of Passive Membrane Permeation from Multiscale Modeling
Dickson, C. J., Horn̆ák, V., Pearlstein, R. A., & Duca, J. S. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b11215 · Cited by 131
Montero, J., Marí, M., Colell, A., Morales, A., Basáñez, G., García‐Ruiz, C., & Fernández-Checa, J. C. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.02.010 · Cited by 130
Malondialdehyde epitopes as mediators of sterile inflammation
Busch, C. J., & Binder, C. J. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.06.016 · Cited by 129
Kasikara, C., Kumar, S., Kimani, S. G., Tsou, W., Geng, K., Davra, V., Sriram, G., Devoe, C., Nguyen, K.-Q. N., Lewis-Antes, A., et al. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0350 · Cited by 129
Relation Between Mitochondrial Membrane Potential and ROS Formation
Suski, J. M., Lebiedzińska, M., Bonora, M., Pinton, P., Duszyński, J., & Wieckowski, M. R. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7831-1_22 · Cited by 128
Ide, Y., Waki, M., Hayasaka, T., Nishio, T., Morita, Y., Tanaka, H., Sasaki, T., Koizumi, K., Matsunuma, R., Hosokawa, Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061204 · Cited by 126
Zhitomirsky, B., Yunaev, A., Kreiserman, R., Kaplan, A., Stark, M., & Assaraf, Y. G. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1227-0 · Cited by 126
Self-citationYoval‐Sánchez, B., & Rodríguez‐Zavala, J. S. (2012) · Chemical Research in Toxicology · doi:10.1021/tx2005184 · Cited by 125
Carbonic anhydrase XII is a new therapeutic target to overcome chemoresistance in cancer cells
Kopecka, J., Campia, I., Jacobs, A., Frei, A. P., Ghigo, D., Wollscheid, B., & Riganti, C. (2015) · Oncotarget · doi:10.18632/oncotarget.2882 · Cited by 122
Self-citationBiomarkers of oxidative and nitro‐oxidative stress: conventional and novel approaches
Gašparović, A. Č., Žarković, N., Žarković, K., Semen, K. O., Kaminskyy, D. V., Yelisyeyeva, O. P., & Bottari, S. P. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13673 · Cited by 120
Self-citationGelsomino, G., Corsetto, P. A., Campia, I., Montorfano, G., Kopecka, J., Castella, B., Gazzano, E., Ghigo, D., Rizzo, A. M., & Riganti, C. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-137 · Cited by 119
Self-citationBcl2L13 is a ceramide synthase inhibitor in glioblastoma
Jensen, S. A., Calvert, A. E., Volpert, G., Kouri, F. M., Hurley, L., Luciano, J. P., Wu, Y., Chalastanis, A., Futerman, A. H., & Stegh, A. H. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1316700111 · Cited by 118
Shojaei, S., Koleini, N., Samiei, E., Aghaei, M., Cole, L., Alizadeh, J., Islam, M. R., Vosoughi, A. R., Albokashy, M., Butterfield, Y. S. N., et al. (2019) · FEBS Journal · doi:10.1111/febs.15069 · Cited by 118
Pennington, E. R., Funai, K., Brown, D. A., & Shaikh, S. R. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2019.03.012 · Cited by 116
Bernardes, N., & Fialho, A. M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123871 · Cited by 115
4-hydroxynonenal-mediated signaling and aging
Zhang, H., & Forman, H. J. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.11.032 · Cited by 114
Lipid dependence of ABC transporter localization and function
Klappe, K., Hummel, I., Hoekstra, D., & Kok, J. W. (2009) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2009.07.004 · Cited by 113
Rho GTPases as therapeutic targets in cancer (Review)
Cardama, G. A., González, N., Maggio, J., Menna, P. L., & Gomez, D. E. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4093 · Cited by 110
Schnitzer, S. E., Weigert, A., Zhou, J., & Brüne, B. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0156 · Cited by 109
Monteiro, J. P., Oliveira, P. J., & Jurado, A. S. (2013) · Progress in Lipid Research · doi:10.1016/j.plipres.2013.06.002 · Cited by 107
Mitochondria-Associated Membranes As Networking Platforms and Regulators of Cancer Cell Fate
Sassano, M. L., van Vliet, A. R., & Agostinis, P. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00174 · Cited by 107
Rab GTPases: Switching to Human Diseases
Guadagno, N. A., & Progida, C. (2019) · Cells · doi:10.3390/cells8080909 · Cited by 106
Gao, N., Budhraja, A., Cheng, S., Liu, E.-H., Chen, J., Yang, Z., Chen, D., Zhang, Z., & Shi, X. (2011) · Cell Death and Disease · doi:10.1038/cddis.2011.22 · Cited by 104
Praharaj, P. P., Naik, P. P., Panigrahi, D. P., Bhol, C. S., Mahapatra, K. K., Patra, S., Sethi, G., & Bhutia, S. K. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2990-x · Cited by 104
Stimulation of HeLa cell growth by physiological concentrations of 4‐hydroxynonenal
Žarković, N., Ilic, Z., Jurin, M., Schaur, R. J., Puhl, H., & Esterbauer, H. (1993) · Cell Biochemistry and Function · doi:10.1002/cbf.290110409 · Cited by 100
Gouazé‐Andersson, V., Yu, J., Kreitenberg, A. J., et al. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.09.005 · Cited by 100
Trans‐4‐hydroxy‐2‐hexenal is a neurotoxic product of docosahexaenoic (22:6; n‐3) acid oxidation
Long, E. K., Murphy, T. C., Leiphon, L. J., Watt, J. A., Morrow, J. D., Milne, G. L., Howard, J. R. H., & Picklo, M. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05175.x · Cited by 100
Moriceau, G., Ory, B., Mitrofan, L. M., Riganti, C., Blanchard, F., Brion, R., Charrier, C., Battaglia, S., Pilet, P., Denis, M. G., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0578 · Cited by 98
Self-citationFarnesyl diphosphate synthase is important for the maintenance of glioblastoma stemness
Kim, H. Y., Kim, D.-K., Bae, S.-H., Gwak, H., Jeon, J. H., Kim, J.-K., Lee, B. I., You, H. J., Shin, D. H., Kim, Y.-H., et al. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0166-2 · Cited by 98
Venkatraman, G., Benesch, M. G. K., Tang, X., Dewald, J. W., McMullen, T. P. W., & Brindley, D. N. (2014) · The FASEB Journal · doi:10.1096/fj.14-262659 · Cited by 95
Shen, S., Li, Y., Li, L., Bai, Y., Cai, C., & Liu, H. (2017) · Journal of Chromatography B · doi:10.1016/j.jchromb.2017.10.004 · Cited by 91
4-Hydroxy Hexenal Derived from Docosahexaenoic Acid Protects Endothelial Cells via Nrf2 Activation
Ishikado, A., Morino, K., Nishio, Y., Nakagawa, F., Mukose, A., Sono, Y., Nagisa, Y., Kondo, K., Sekine, O., Yoshizaki, T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069415 · Cited by 89
P-Glycoprotein and Membrane Roles in Multidrug Resistance
Ferreira, R. J., dos Santos, D. J. V. A., & Ferreira, M. U. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.36 · Cited by 89
Apoptosis-induced changes in mitochondrial lipids
Crimi, M., & Esposti, M. D. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.09.014 · Cited by 88
Could drugs inhibiting the mevalonate pathway also target cancer stem cells?
Likus, W., Siemianowicz, K., Bieńk, K., Pakula, M. M., Pathak, H., Dutta, C., Wang, Q., Shojaei, S., Assaraf, Y. G., Ghavami, S., et al. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.02.001 · Cited by 88
Self-citationAssays for the Measurement of Lipid Peroxidation
Gašparović, A. Č., Jaganjac, M., Mihaljević, B., Šunjić, S. B., & Žarković, N. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-239-1_19 · Cited by 87
Self-citationLin, H., Mahon, K. L., Weir, J. M., Mundra, P. A., Spielman, C., Briscoe, K. P., Gurney, H., Mallesara, G., Marx, G. M., Stockler, M. R., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.30903 · Cited by 87
Riganti, C., Voena, C., Kopecka, J., Corsetto, P. A., Montorfano, G., Enrico, E., Costamagna, C., Rizzo, A. M., Ghigo, D., & Bosia, A. (2011) · Molecular Pharmaceutics · doi:10.1021/mp2001389 · Cited by 86
Self-citationWaller, D. D., Park, J., & Tsantrizos, Y. S. (2019) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2019.1568964 · Cited by 86
Milković, L., Gašparović, A. Č., & Žarković, N. (2014) · Free Radical Research · doi:10.3109/10715762.2014.999056 · Cited by 85
Self-citationCholesterol: Coupling between membrane microenvironment and ABC transporter activity
dos Santos, S. M., Weber, C.-C., Franke, C., Müller, W. E., & Eckert, G. P. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.12.202 · Cited by 85
Raft and cytoskeleton associations of an ABC transporter: P‐glycoprotein
Bacsó, Z., Nagy, H., Goda, K., Bene, L., Fenyvesi, F., Matkó, J., & Szabó, G. (2004) · Cytometry Part A · doi:10.1002/cyto.a.20081 · Cited by 84
Flip-Flop of Doxorubicin across Erythrocyte and Lipid Membranes
Regev, R., & Eytan, G. D. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00326-2 · Cited by 82
Mol, M., Regazzoni, L., Altomare, A., Degani, G., Carini, M., Vistoli, G., & Aldini, G. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.01.036 · Cited by 81
Role of cholesterol homeostasis and its efflux pathways in cancer progression
Sharma, B., & Agnihotri, N. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105377 · Cited by 80
Yang, B., Fritsche, K. L., Beversdorf, D. Q., Gu, Z., Lee, J. C., Folk, W. R., Greenlief, C. M., & Sun, G. Y. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00642 · Cited by 80
Alexa‐Stratulat, T., Pešić, M., Gašparović, A. Č., Trougakos, I. P., & Riganti, C. (2019) · Drug Resistance Updates · doi:10.1016/j.drup.2019.100643 · Cited by 80
Self-citationProgestin modulates the lipid profile and sensitivity of breast cancer cells to docetaxel
Schlaepfer, I. R., Hitz, C. A., Gijón, M., Bergman, B., Eckel, R., & Jacobsen, B. M. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.08.005 · Cited by 75
Bochicchio, D., Panizon, E., Ferrando, R., Monticelli, L., & Rossi, G. (2015) · The Journal of Chemical Physics · doi:10.1063/1.4932159 · Cited by 75
Cancer growth regulation by 4-hydroxynonenal
Gašparović, A. Č., Milković, L., Šunjić, S. B., & Žarković, N. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.01.030 · Cited by 75
Self-citationRadeva, G., Perabo, J., & Sharom, F. J. (2005) · FEBS Journal · doi:10.1111/j.1742-4658.2005.04905.x · Cited by 72
Huang, Z., Jiang, J., Tyurin, V. A., Zhao, Q., Mnuskin, A., Ren, J., Belikova, N. A., Feng, W., Kurnikov, I. V., & Kagan, V. E. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.02.016 · Cited by 72
Ceramide synthases in cancer therapy and chemoresistance
Brachtendorf, S., El-Hindi, K., & Grösch, S. (2019) · Progress in Lipid Research · doi:10.1016/j.plipres.2019.04.002 · Cited by 71
Lipid mediators involved in the oxidative stress and antioxidant defence of human lung cancer cells
Gęgotek, A., Nikliński, J., Žarković, N., Žarković, K., Waeg, G., Łuczaj, W., Charkiewicz, R., & Skrzydlewska, E. (2016) · Redox Biology · doi:10.1016/j.redox.2016.08.010 · Cited by 70
Mollinedo, F., Fernández, M., Hornillos, V., Delgado, J., Amat‐Guerri, F., Acuña, A. U., Nieto-Miguel, T., Villa-Pulgarín, J. A., González-García, C., Ceña, V., et al. (2011) · Cell Death and Disease · doi:10.1038/cddis.2011.41 · Cited by 67
4-Hydroxynonenal modulation of p53 family gene expression in the SK-N-BE neuroblastoma cell line
Laurora, S., Tamagno, E., Briatore, F., Bardini, P., Pizzimenti, S., Toaldo, C., Reffo, P., Costelli, P., Dianzani, M. U., Danni, O., et al. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.10.014 · Cited by 65
Coscia, M., Pantaleoni, F., Riganti, C., Vitale, C., Rigoni, M. M., Peola, S., Castella, B., Foglietta, M., Griggio, V., Drandi, D., et al. (2011) · Leukemia · doi:10.1038/leu.2011.12 · Cited by 65
Self-citationStromal regulation of prostate cancer cell growth by mevalonate pathway enzymes HMGCS1 and HMGCR
Ashida, S., Kawada, C., & Inoue, K. (2017) · Oncology Letters · doi:10.3892/ol.2017.7025 · Cited by 62
Ferreira, R. J., Bonito, C. A., Cordeiro, M. N. D. S., Ferreira, M. U., & dos Santos, D. J. V. A. (2017) · Scientific Reports · doi:10.1038/s41598-017-15452-z · Cited by 61
Sethunath, V., Hu, H., Angelis, C. D., Veeraraghavan, J., Qin, L., Wang, N., Simon, L. M., Wang, T., Fu, X., Nardone, A., et al. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0756 · Cited by 61
Kiebish, M. A., Han, X., Cheng, H., & Seyfried, T. N. (2009) · ASN NEURO · doi:10.1042/an20090011 · Cited by 60
Hematopoiesis and RAS-driven myeloid leukemia differentially require PI3K isoform p110α
Gritsman, K., Yuzugullu, H., Von, T., Yan, H., Clayton, L. K., Fritsch, C. M., Maira, S.-M., Hollingworth, G. J., Choi, C. H., Khandan, T., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci69927 · Cited by 57
He, Y., Su, J., Lan, B., Gao, Y., & Zhao, J. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s194770 · Cited by 57
Dietary lipids and their oxidized products in Alzheimer's disease
Corsinovi, L., Biasi, F., Poli, G., Leonarduzzi, G., & Isaia, G. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100208 · Cited by 56
Activation of LXRɑ/β by cholesterol in malignant ascites promotes chemoresistance in ovarian cancer
Kim, S., Lee, M., Dhanasekaran, D. N., & Song, Y. S. (2018) · BMC Cancer · doi:10.1186/s12885-018-5152-5 · Cited by 56
Gstalder, C., Ader, I., & Cuvillier, O. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0167 · Cited by 55
Wegner, M.-S., Schömel, N., Gruber, L., Örtel, S. B., Kjellberg, M. A., Mattjus, P., Kurz, J., Trautmann, S., Peng, B., Wegner, M., et al. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2799-7 · Cited by 55
Colon cancer cell chemosensitisation by fish oil emulsion involves apoptotic mitochondria pathway
Granci, V., Cai, F., Lecumberri, E., Clerc, A., Dupertuis, Y. M., & Pichard, C. (2012) · British Journal Of Nutrition · doi:10.1017/s000711451200308x · Cited by 54
PGRMC1 contributes to doxorubicin-induced chemoresistance in MES-SA uterine sarcoma
Lin, S., May, E. W. S., Chang, J., Hu, R., Wang, L. H.-C., & Chan, H. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1831-9 · Cited by 53
Plumb, J., Luo, W., & Kerr, D. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.133 · Cited by 53
Electron Flow and Cholesterol‐Side‐Chain Cleavage in Ovarian Mitochondria
Robinson, J., & Stevenson, P. M. (1971) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1971.tb19651.x · Cited by 52
Kopecka, J., Porto, S., Lusa, S., Gazzano, E., Salzano, G., Pinzón‐Daza, M. L., Giordano, A., Desiderio, V., Ghigo, D., Rosa, G. D., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8012 · Cited by 52
Self-citationWu, Y., Si, R., Tang, H., He, Z., Zhu, H. L., Wang, L., Fan, Y., Xia, S., He, Z., & Wang, Q. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.01.035 · Cited by 51
Houthuijzen, J. M., Daenen, L. G. M., Roodhart, J. M. L., Oosterom, I., van Jaarsveld, M. T. M., Govaert, K. M., Smith, M. E., Sadatmand, S. J., Rosing, H., Kruse, F., et al. (2014) · Nature Communications · doi:10.1038/ncomms6275 · Cited by 50
RhoA Silencing Reverts the Resistance to Doxorubicin in Human Colon Cancer Cells
Doublier, S., Riganti, C., Voena, C., Costamagna, C., Aldieri, E., Pescarmona, G., Ghigo, D., & Bosìa, A. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0251 · Cited by 50
Self-citationSridevi, P., Alexander, H., Laviad, E. L., Min, J., Mesika, A., Hannink, M., Futerman, A. H., & Alexander, S. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.09.027 · Cited by 50
Lipid Regulation of the ABCB1 and ABCG2 Multidrug Transporters
Hegedüs, C., Telbisz, Á., Hegedűs, T., Sarkadi, B., & Özvegy‐Laczka, C. (2015) · Advances in cancer research · doi:10.1016/bs.acr.2014.10.004 · Cited by 48
Jung, J. H., Lee, M. Y., Choi, D., Lee, J. W., You, S., Lee, K. Y., Kim, J., & Kim, K. P. (2014) · PROTEOMICS · doi:10.1002/pmic.201400243 · Cited by 48
Domicevica, L., Koldsø, H., & Biggin, P. C. (2017) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2017.12.022 · Cited by 48
Chiu, C.-C., Frangou, S., Chang, C.-J., Chiu, W.-C., Liu, H.-C., Sun, I.-W., Liu, S.-I., Lu, M.-L., Chen, C.-H., Huang, S.-Y., et al. (2012) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.015784 · Cited by 47
Xiang, L., Liu, Z., Huan, Q., Su, P., Du, G.-J., Wang, Y., Gao, P., & Zhou, G. (2012) · Diagnostic Pathology · doi:10.1186/1746-1596-7-32 · Cited by 47
Kopecka, J., Porto, S., Lusa, S., Gazzano, E., Salzano, G., Giordano, A., Desiderio, V., Ghigo, D., Caraglia, M., Rosa, G. D., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5058 · Cited by 47
Self-citationBrachtendorf, S., Wanger, R. A., Birod, K., Thomas, D., Trautmann, S., Wegner, M.-S., Fuhrmann, D. C., Brüne, B., Geißlinger, G., & Grösch, S. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2018.07.011 · Cited by 47
Dharmapuri, G., Ravinder, D., Philip, G. H., & Kalle, A. M. (2015) · Leukemia Research · doi:10.1016/j.leukres.2015.02.013 · Cited by 46
Gustot, A., Smriti, S., Ruysschaert, J., Mchaourab, H. S., & Govaerts, C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.079673 · Cited by 46
Assessment of pathological response to therapy using lipid mass spectrometry imaging
Patterson, N. H., Alabdulkarim, B., Lazaris, A., Thomas, A., Marcinkiewicz, M. M., Gao, Z., Vermeulen, P. B., Chaurand, P., & Metrakos, P. P. (2016) · Scientific Reports · doi:10.1038/srep36814 · Cited by 46
Cancer: Untethering Mitochondria from the Endoplasmic Reticulum?
Herrera-Cruz, M. S., & Simmen, T. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00105 · Cited by 46
Levin, M., Stark, M., Berman, B., & Assaraf, Y. G. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1626-x · Cited by 46
Self-citationTelbisz, Á., Özvegy‐Laczka, C., Hegedűs, T., Váradi, A., & Sarkadi, B. (2012) · Biochemical Journal · doi:10.1042/bj20121485 · Cited by 45
Ge, W., Yuan, M., Ceylan, A. F., Wang, X., & Ren, J. T. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.12.014 · Cited by 45
Timuçin, A. C., & Başağa, H. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.11.010 · Cited by 45
Insights in the chemical components of liposomes responsible for P-glycoprotein inhibition
Kopecka, J., Salzano, G., Campia, I., Lusa, S., Ghigo, D., Rosa, G. D., & Riganti, C. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.06.013 · Cited by 44
Self-citationDisabled cell density sensing leads to dysregulated cholesterol synthesis in glioblastoma
Kambach, D. M., Halim, A. S., Cauer, A. G., Sun, Q., Tristan, C. A., Celiku, O., Kesarwala, A. H., Shankavaram, U. T., Batchelor, E., & Stommel, J. M. (2017) · Oncotarget · doi:10.18632/oncotarget.14740 · Cited by 44
Sphingolipid abnormalities in cancer multidrug resistance: Chicken or egg?
Lee, W., & Kolesnick, R. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.06.017 · Cited by 44
Coarse-grained molecular dynamics simulations reveal lipid access pathways in P-glycoprotein
Barreto-Ojeda, E., Corradi, V., Gu, R., & Tieleman, D. P. (2018) · The Journal of General Physiology · doi:10.1085/jgp.201711907 · Cited by 44
Rauch, C. (2009) · European Biophysics Journal · doi:10.1007/s00249-009-0429-x · Cited by 43
ERK2 is essential for the growth of human epithelioid malignant mesotheliomas
Shukla, A., Hillegass, J., MacPherson, M. B., Beuschel, S. L., Vacek, P. M., Butnor, K. J., Pass, H. I., Carbone, M., Testa, J. R., Heintz, N. H., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25763 · Cited by 43
Liver X Receptor Ligands Suppress Ubiquitination and Degradation of LXRα by Displacing BARD1/BRCA1
Kim, K. H., Yoon, J. M., Choi, A. H., Kim, W. S., Lee, G. Y., & Kim, J. B. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0295 · Cited by 42
Jovanović, O., Pashkovskaya, A. A., Annibal, A., Vazdar, M., Burchardt, N., Sansone, A., Gille, L., Fedorova, M., Ferreri, C., & Pohl, E. E. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.10.422 · Cited by 41
The small GTPases Rab5 and RalA regulate intracellular traffic of P-glycoprotein
Fu, D., van Dam, E. M., Brymora, A., Duggin, I. G., Robinson, P. J., & Roufogalis, B. D. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.03.023 · Cited by 41
Rab6c, a new member of the Rab gene family, is involved in drug resistance in MCF7/AdrR cells
Shan, J., Mason, J. M., Yuan, L., et al. (2000) · Gene · doi:10.1016/s0378-1119(00)00395-4 · Cited by 40
Rigoni, M. M., Riganti, C., Vitale, C., Griggio, V., Campia, I., Robino, M., Foglietta, M., Castella, B., Sciancalepore, P., Buondonno, I., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4006 · Cited by 39
Self-citationLipid-Dependent Alternating Access Mechanism of a Bacterial Multidrug ABC Exporter
Immadisetty, K., Hettige, J., & Moradi, M. (2019) · ACS Central Science · doi:10.1021/acscentsci.8b00480 · Cited by 38
HNE-protein adducts formation in different pre-carcinogenic stages of hepatitis in LEC rats
Márquez-Quiñones, A., Gašparović, A. Č., Žarković, K., Fattel‐Fazenda, S., Villa‐Treviño, S., Waeg, G., Žarković, N., & Guéraud, F. (2009) · Free Radical Research · doi:10.3109/10715760903338071 · Cited by 37
Self-citationVerlekar, D. U., Wei, S., Cho, H., Yang, S., & Kang, M. H. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0964-4 · Cited by 37
Zoledronic Acid Overcomes Chemoresistance and Immunosuppression of Malignant Mesothelioma
Salaroglio, I. C., Campia, I., Kopecka, J., Gazzano, E., Orecchia, S., Ghigo, D., & Riganti, C. (2015) · Oncotarget · doi:10.18632/oncotarget.2731 · Cited by 36
Self-citationFerrándiz‐Huertas, C., Fernández-Carvajal, A. M., & Ferrer-Montiel, A. V. (2010) · International Journal of Cancer · doi:10.1002/ijc.25310 · Cited by 36
Bao, H., Dalal, K., Wang, V., Rouiller, I., & Duong, F. (2013) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2013.03.024 · Cited by 36
Permeability of a Fluid Lipid Bilayer to Short-Chain Alcohols from First Principles
Comer, J. R., Schulten, K. J., & Chipot, C. J. (2017) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.7b00264 · Cited by 36
Recent Advances in the Development of Mammalian Geranylgeranyl Diphosphate Synthase Inhibitors
Haney, S. L., Wills, V. S., Wiemer, D. F., & Holstein, S. A. (2017) · Molecules · doi:10.3390/molecules22060886 · Cited by 36
Verbrugge, S. E., Al, M., Assaraf, Y. G., Kammerer, S., Chandrupatla, D. M. S. H., Honeywell, R. J., Musters, R. J. P., Giovannetti, E., O’Toole, T. G., Scheffer, G. L., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6169 · Cited by 35
Self-citationScheim, D. E. (2009) · Lipids in Health and Disease · doi:10.1186/1476-511x-8-54 · Cited by 34
Mesev, E. V., Miller, D. S., & Cannon, R. E. (2017) · Molecular Pharmacology · doi:10.1124/mol.116.107169 · Cited by 31
Hu, Y., Zang, J., Qin, X., et al. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s124757 · Cited by 30
Domicevica, L., Koldsø, H., & Biggin, P. C. (2017) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2017.09.002 · Cited by 29
Chantemargue, B., Meo, F. D., Berka, K., Picard, N., Arnion, H., Essig, M., Marquet, P., Otyepka, M., & Trouillas, P. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.02.029 · Cited by 29
Self-citationCoarse grain lipid–protein molecular interactions and diffusion with MsbA flippase
Ward, A. B., Guvench, O., & Hills, R. D. (2012) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.24108 · Cited by 28
Camarillo, J. M., Ullery, J. C., Rose, K. L., & Marnett, L. J. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00374 · Cited by 28
Ye, D. M., Ye, S., Yu, S., Shu, F. F., Xu, S., Chen, Q. Q., Wang, Y. L., Tang, Z., & Pan, C. (2019) · Neoplasma · doi:10.4149/neo_2018_180820n633 · Cited by 28
Rictor/mTORC2 deficiency enhances keratinocyte stress tolerance via mitohormesis
Tassone, B., Saoncella, S., Neri, F., Ala, U., Brusa, D., Magnuson, M. A., Provero, P., Oliviero, S., Riganti, C., & Calautti, E. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.8 · Cited by 26
Self-citationThurgood, L. A., Dwyer, E. S., Lower, K. M., Chataway, T., & Kuss, B. J. (2019) · British Journal of Haematology · doi:10.1111/bjh.15751 · Cited by 25
Cited by
Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics
Jin, H.-R., Wang, J., Wang, Z.-J., Xi, M.-J., Xia, B.-H., Deng, K., & Yang, J.-L. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01498-2 · Cited by 481
Lipid metabolism in cancer progression and therapeutic strategies
Fu, Y., Zou, T., Shen, X., Nelson, P. J., Li, J., Wu, C., Yang, J., Zheng, Y., Bruns, C., Zhao, Y., et al. (2021) · MedComm · doi:10.1002/mco2.27 · Cited by 393
Tumour fatty acid metabolism in the context of therapy resistance and obesity
Hoy, A. J., Nagarajan, S. R., & Butler, L. M. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00388-4 · Cited by 392
Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors
Dallavalle, S., Dobričić, V., Lazzarato, L., Gazzano, E., Machuqueiro, M., Pajeva, I., Tsakovska, I., Zidar, N., & Fruttero, R. (2020) · Drug Resistance Updates · doi:10.1016/j.drup.2020.100682 · Cited by 318
Self-citationEmerging therapies in cancer metabolism
Xiao, Y., Yu, T.-J., Xu, Y., Ding, R., Wang, Y.-P., Jiang, Y.-Z., & Shao, Z.-M. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.07.006 · Cited by 256
Metadata
- Authors
- Kopecka, J., Trouillas, P., Gašparović, A. Č., Gazzano, E., Assaraf, Y. G., & Riganti, C.
- Venue
- Drug Resistance Updates
- Publisher
- Elsevier BV
- Published
- 2020-03
- Volume
- 49
- Pages
- 100670
- ISSN
- 1368-7646 (ISSN-L)
- OpenAlex
- W2990802341
- Cited by
- 291
- References
- 224
- FWCI
- 8.16
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.